BREAKING NEWS: CRAWFORD STEPS DOWN AS FDA CHIEF
FDA Commissioner Lester Crawford stunned the industry with the announcement
late Friday that he was stepping down from the post he had fought to gain just
two months before. Crawford, 67, whose nomination was delayed by an anonymous
allegation of personal misconduct and political opposition to the agency's decision
not to approve the Plan B contraceptive, gave no specific reason for his resignation.
He was confirmed by the Senate on July 18, after having served as acting commissioner
and deputy commissioner. The White House reportedly named Andrew von Eschenbach, the head
of the National Cancer Institute, as acting commissioner.